Vernalis is a pharmaceutical firm that develops and commercializes therapeutics for the treatment of cancer and nervous system disorders... Read more
Vernalis is a pharmaceutical firm that develops and commercializes therapeutics for the treatment of cancer and nervous system disorders... Read more
News
Apr 08, 2024
MarketScreener
Vernalis, PLC: C4X Discovery : Vernalis announces a drug discovery collaboration with C4X Discovery in inflammatory disease
Feb 20, 2024
BioSpace
Vernalis, PLC: Hox Therapeutics and Vernalis announce a drug discovery collaboration in oncology
Sep 25, 2023
Contract Pharma
Vernalis, PLC: Pierre Fabre, Vernalis Enter Oncology Drug Discovery Alliance
Sep 25, 2023
Pharamceutical Technology
Vernalis, PLC: Pierre Fabre announces another partnership to expand oncology R&D
Sep 28, 2022
FinanzNachrichten
Vernalis, PLC: Vernalis Research, a fully owned subsidiary of HitGen Inc., and Contera Pharma A/S announce a strategic collaboration in the field of RNA-targeting small molecules in neurology
Sep 06, 2022
ChinaBio Today
Vernalis, PLC: Vernalis Collaborates with Unison to Discover Drugs for "Undruggable" Bacterial Target
Nov 01, 2021
FinanzNachrichten
Vernalis, PLC: Vernalis Research - a Fully Owned Subsidiary of HitGen Inc - and Hannibal Innovation Announce the Creation of Dania Therapeutics ApS
Oct 13, 2020
PharmaLeaders
Vernalis: HitGen to acquire fragment and structure-based biotech company Vernalis
Oct 12, 2020
Seeking Alpha
Vernalis: Ligand divests Vernalis research operations for $25M
Oct 12, 2020
The Pharma Letter
Vernalis: Ligand sells Vernalis, just two years after buying the UK firm
Vernalis, PLC Competitors
1
2
3
4
5
6
7
8
9
10